Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 1 Rhabdoid Tumor 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

X-Rays 7 Phantoms, Imaging 7 Magnetic Resonance Spectroscopy 7 Specimen Handling 6 Nuclear Medicine Department, Hospital 5 Biopsy 4 tazemetostat 3 Cyclophosphamide 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Vincristine 2 Topotecan 2 Methotrexate 2 LY3023414 2 Etoposide 2 Cisplatin 2 Carboplatin 2 talazoparib 1 selinexor 1 pembrolizumab 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rhabdoid Tumor × MLN 8237 × 90 days × Clear all

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡